The Medical Lead, Chronic Lymphocytic Leukemia (CLL) helps shape and deliver AstraZeneca’s US Medical Affairs strategy for a priority hematology oncology indication. The role leads the Core Medical Team, develops and executes the integrated medical plan, and uses scientific, clinical, customer, and multi-channel insights to inform evidence generation, product development, and launch readiness. It collaborates across Medical, Clinical Development, Patient Safety, Commercial, Market Access, and Field Medical teams to advance science-driven strategies with impact for patients and the CLL community. The position manages investigator-initiated studies that complement AstraZeneca’s clinical development plan; leads the indication- or asset-level real-world evidence strategy from concept through execution and communication; and creates the US publication plan for generated evidence. It also provides medical review and input for key materials, engages strategic external partners, contributes to safety discussions, and supports scientific exchange with field medical and key account teams. This is a hybrid role based in Gaithersburg, Maryland, with an onsite requirement. National and international travel may be required, as appropriate, up to approximately 30% of the time.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree